SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Industry–Academic Relationship in a New Era of Drug Discovery
4 references·0 citing·21 second hop
Industry–Academic Relationship in a New Era of Drug Discovery (2016)Industry–Academic Relationship in a New E…Academic drug discovery within the United Kingdom: a reassessment (2015)Academic drug discovery withi…Reducing waste from incomplete or unusable reports of biomedical research (2014)Reducing waste from incomplet…Increasing value and reducing waste in research design, conduct, and analysis (2014)Increasing value and reducing…Diagnosing the decline in pharmaceutical R&D efficiency (2012)Diagnosing the decline in pha…UK academic drug discovery (2013)Ten Years of Medicinal Chemistry (2005–2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public–Private Partnerships (2016)Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options (2022)Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests (1999)Why Most Discovered True Associations Are Inflated (2008)Believe it or not: how much can we rely on published data on potential drug targets? (2011)The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument (2016)The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses (2016)“Everyone wants to do the model work, not the data work”: Data Cascades in High-Stakes AI (2021)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (2015)The COMET Handbook: version 1.0 (2017)Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension (2020)Rise and fall of modern medicine (1999)Can the pharmaceutical industry reduce attrition rates? (2004)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Are Ideas Getting Harder to Find? (2020)Generating Theory by Abduction (2021)
this work references cited by second hop

References

  • 2012Diagnosing the decline in pharmaceutical R&D efficiency1,978 cited
  • 2014Increasing value and reducing waste in research design, conduct, and analysis1,597 cited
  • 2014Reducing waste from incomplete or unusable reports of biomedical research1,315 cited
  • 2015Academic drug discovery within the United Kingdom: a reassessment25 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work